Please ensure Javascript is enabled for purposes of website accessibility

Teladoc Health Soars After Reporting Strong Q4 Results

By Jim Crumly – Feb 26, 2020 at 7:31PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors also anticipate a boost from the COVID-19 coronavirus scare.

Virtual healthcare provider Teladoc Health (TDOC -6.99%) reported fourth-quarter earnings that beat expectations and gave strong guidance for the year ahead, propelling the stock up 15% in after-hours trading Wednesday. Revenue grew 27% to $156 million, above the top end of guidance the company issued three months ago and above the $153 million analysts were expecting. The company lost $0.26 per share, compared with Wall Street expectations for a loss of $0.33.

Teladoc gets most of its revenue from recurring subscription-access fees, and that revenue grew 24% to $127 million. Revenue from visit fees grew even faster, up 47% to $29.5 million, reflecting the fact that established users make more visits over time as they grow more comfortable with the service. Total visits grew 44% to 1.24 million, above guidance of 1.0 million to 1.2 million.

Teladoc added 1.7 million paid members in the U.S. in Q4 for a total of 36.7 million, a 5% increase since Q3 and 61% above the membership total a year ago.

Mother and child talking to a doctor on a tablet.

Image source: Teladoc Health.

Guidance for next quarter and for the full year was well above what analysts had been thinking. The company expects revenue in Q1 to be $169 million to $172 million, compared with the $164 million analyst consensus. For 2020, Teladoc anticipates revenue between $695 million and $710 million, well above expectations of $693 million.

Teladoc Health stock has had a great 2020 so far, up 40% as of the close Wednesday. Part of the reason for investor optimism is the potential impact of the COVID-19 coronavirus, which could cause patients to seek remote health solutions rather than visiting waiting rooms.

The warning from the Centers for Disease Control and Prevention on Tuesday gave a boost to Teladoc stock, since it said that healthcare facilities should be prepared to increase the use of telehealth systems. When asked on the conference call, Teladoc management said that its guidance doesn't yet include impact from COVID-19, leaving open the possibility of even further improvement in the company's outlook should the virus spread to the U.S.

Jim Crumly owns shares of Teladoc Health. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$26.23 (-6.99%) $-1.97

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.